A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.

Saved in:
Bibliographic Details
Title: A phase II randomized controlled trial of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy.
Authors: Alibhai SMH; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada. shabbir.alibhai@uhn.ca.; Toronto General Hospital, 200 Elizabeth St Room EN14-214, Toronto, Ontario, M5G 2C4, Canada. shabbir.alibhai@uhn.ca., Santa Mina D; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada.; Cancer Care Ontario, York University, Toronto, ON, M3J 1P3, Canada., Ritvo P; Cancer Care Ontario, York University, Toronto, ON, M3J 1P3, Canada., Tomlinson G; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada.; Cancer Care Ontario, York University, Toronto, ON, M3J 1P3, Canada., Sabiston C; University of Toronto, Toronto, ON, M5S 2J7, Canada., Krahn M; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada.; Cancer Care Ontario, York University, Toronto, ON, M3J 1P3, Canada., Durbano S; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada., Matthew A; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada., Warde P; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada.; Cancer Care Ontario, York University, Toronto, ON, M3J 1P3, Canada.; University of Toronto, Toronto, ON, M5S 2J7, Canada., O'Neill M; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada., Timilshina N; University Health Network, University of Toronto, Toronto, ON, M5G 2C4, Canada., Segal R; The Ottawa Hospital Cancer Centre, University of Ottawa, Ottawa, ON, K1N 6N5, Canada., Culos-Reed N; University of Calgary, Calgary, AB, T2N 1N4, Canada.
Source: BMC cancer [BMC Cancer] 2019 Jan 03; Vol. 19 (1), pp. 2. Date of Electronic Publication: 2019 Jan 03.
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Equivalence Trial
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1471-2407
DOI:10.1186/s12885-018-5189-5